Pms5 Use of an Algorithm Within a Multidisciplinary Consultation for the Management of Patients With Rheumatoid Arthritis Candidates for Biological Therapy - A Strategy for Optimizing Costs

Santos-Moreno, P.; Peralta, L. Villarreal; Cabrera, Manuel Rodrigo de la O; Zakzuk, N. Alvis; Buitrago-Garcia, D.

doi:10.1016/j.vhri.2019.08.298

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Socioeconomic difficulties faced by hospitals are related to direct costs which involve examinations, laboratory tests, hospital admission, conventional synthetic and biologic disease modifying drugs, caregiver assistance, transportation and equipment. The improvement in RA symptoms through rheumatologist and nurse-led care (12), the use of conventional DMARDs instead of the more expensive biological therapy (13), the use of subcutaneous-injected biologic agents instead of the more expensive infused biologic therapy, a larger clinical setting with high patient volume involving a more efficient use of equipment (1), avoiding switching to another anti-TNF or to a biologic with a different mechanism of action (14), earlier treatment initiation, improved treatment strategies with conventional DMARDs, including triple therapy (3), negotiated cost discounts and utilization limits (15,16) can be used for cost optimization.…”

Section: Discussionmentioning

confidence: 99%

Untitled

2019

Ro J Rheumatol.

View full text Add to dashboard Cite

Objective. Rheumatoid arthritis (RA) has direct costs, expressed as hospitalization, tests, drug therapy, physical therapy, assistance, transportation and equipment, and indirect costs caused by work loss. The aim of our study was to evaluate the direct costs of hospitalization in a Romanian clinical setting. Methods. Relationships between the clinical, laboratory, functional parameters and the hospitalization costs were assessed in 50 female RA patients admitted to the Ist Rheumatology Clinic between May and July 2019. The duration of hospitalization ranged between 4 and 11 days. Results. Our study showed that pain was associated with higher hospitalization costs, as the number of painful joints (r = +0.396, p = 0.004) and the Visual Analogue Scale for Pain (r = +0.318, p = 0.025) were significantly correlated with the total costs of hospitalization. A higher DAS28 required higher medication costs (r = +0.434, p = 0.002) and the laboratory exams were more expensive in CRP tests (r = +0.282, p = 0.047). Conclusions. Our study showed that in Romania there are high hospitalization costs for RA. These costs have exceeded per week the 2019 average monthly net salary of ~3,000 RON.

show abstract

Section: Discussionmentioning

confidence: 99%

Untitled

2019

Ro J Rheumatol.

View full text Add to dashboard Cite

show abstract

Pms5 Use of an Algorithm Within a Multidisciplinary Consultation for the Management of Patients With Rheumatoid Arthritis Candidates for Biological Therapy - A Strategy for Optimizing Costs

Cited by 1 publication

References 0 publications

Untitled

Untitled

Contact Info

Product

Resources

About